Related Experiment Video

Updated: Jun 21, 2026

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

NGF inhibits human leukemia proliferation by downregulating cyclin A1 expression through promoting acinus/CtBP2

C B Chan1, X Liu, S-W Jang

  • 1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.

Oncogene
|August 12, 2009
PubMed

Insights

Nerve growth factor (NGF) inhibits leukemia progression by decreasing cyclin A1 expression via the CtBP2/acinus complex. Gambogic amide, an NGF agonist, shows potential for treating human leukemia.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Cyclin A1 is crucial for leukemia progression.
  • Acinus protein regulates cyclin A1 expression, but the mechanism is unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism by which acinus mediates cyclin A1 expression.
  • To investigate the role of nerve growth factor (NGF) and its signaling pathway in regulating cyclin A1 in leukemia.
  • To evaluate the therapeutic potential of gambogic amide in leukemia treatment.

Main Methods:

  • Investigated the interaction between CtBP2 and acinus.
  • Utilized nerve growth factor (NGF) and TrkA signaling.
  • Examined the effect of Akt phosphorylation on acinus.
  • Assessed cyclin A1 and cyclin A2 expression levels.
  • Performed cell proliferation assays and in vivo leukemia models using K562 cells.

Main Results:

  • CtBP2 directly binds acinus, and this interaction is regulated by NGF.
  • NGF, via TrkA and Akt, promotes CtBP2-acinus complex formation, inhibiting cyclin A1 expression.
  • Overexpression of CtBP2 reduces cyclin A1 transcription; CtBP2 depletion blocks NGF's suppressive effect.
  • Gambogic amide, a TrkA agonist, represses cyclin A1 expression, inhibits K562 cell proliferation, and ameliorates leukemia progression in vivo.

Conclusions:

  • NGF downregulates cyclin A1 expression by enhancing CtBP2/acinus complex formation.
  • Gambogic amide demonstrates therapeutic potential for human leukemia by targeting cyclin A1 expression and proliferation.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...